<DOC>
	<DOCNO>NCT00399178</DOCNO>
	<brief_summary>To evaluate efficacy safety Norspan versus Tiperol Retard among OA patient sub-optimally treated current analgesic . Those patient may benefit treatment long lasting analgesic .</brief_summary>
	<brief_title>A Randomised Open Controlled Parallel Group Study Comparing Norspan Tramadol</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>OA diagnosis BS11 great equal 4 base line Not adequately pain relieved 4,000 mg paracetamol daily Treated high potent opioids OA pain Treated regular dose great one week Tramadol , Codeine dextropropoxifene last three month Other chronic condition require frequent analgesic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Norspan versus Tramadol</keyword>
	<keyword>Randomised</keyword>
	<keyword>Efficacy safety</keyword>
	<keyword>OA pain hip and/or knee</keyword>
</DOC>